Molecular Modulation of Prefrontal Cortex: Rational Development of Treatments for Psychiatric Disorders.

Dysfunction of the prefrontal cortex (PFC) is a central feature of many psychiatric disorders, such as attention deficit hyperactivity disorder (ADHD), posttraumatic stress disorder (PTSD), schizophrenia, and bipolar disorder. Thus, understanding molecular influences on PFC function through basic re...

Descripción completa

Detalles Bibliográficos
Publicado en:Behavioral Neuroscience Vol. 125; no. 3; pp. 282 - 297
Autores principales: Gamo, Nao J., Arnsten, Amy F. T.
Formato: Artículo
Publicado: American Psychological Association June 2011
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=507174160&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 507174160
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        07357044
        BEN
      jtl: Behavioral Neuroscience
      issn: 07357044
      maglogo: N
    pubinfo:
      dt: June 2011
      vid: 125
      iid: 3
      pid: 34
      pub: American Psychological Association
    artinfo:
      ui:
        507174160
        10.1037/a0023165
      ppf: 282
      ppct: 15
      formats:
      tig:
        atl: Molecular Modulation of Prefrontal Cortex: Rational Development of Treatments for Psychiatric Disorders.
      aug:
        au:
          Gamo, Nao J.
          Arnsten, Amy F. T.
      su:
        Brain function localization
        Prefrontal cortex
        Mental illness treatment
        Noradrenaline
        Dopamine
        Psychological stress
      sug:
        subj:
          Brain function localization
          Prefrontal cortex
          Mental illness treatment
          Noradrenaline
          Dopamine
          Psychological stress
      ab: Dysfunction of the prefrontal cortex (PFC) is a central feature of many psychiatric disorders, such as attention deficit hyperactivity disorder (ADHD), posttraumatic stress disorder (PTSD), schizophrenia, and bipolar disorder. Thus, understanding molecular influences on PFC function through basic research in animals is essential to rational drug development. In this review, we discuss the molecular signaling events initiated by norepinephrine and dopamine that strengthen working memory function mediated by the dorsolateral PFC under optimal conditions, and weaken working memory function during uncontrollable stress. We also discuss how these intracellular mechanisms can be compromised in psychiatric disorders, and how novel treatments based on these findings may restore a molecular environment conducive to PFC regulation of behavior, thought and emotion. Examples of successful translation from animals to humans include guanfacine for the treatment of ADHD and related PFC disorders, and prazosin for the treatment of PTSD. Reprinted by permission of the publisher.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N